Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
3.500
+0.080 (2.34%)
At close: Nov 19, 2026, 4:00 PM EST
3.500
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:10 PM EST
Clene Employees
As of December 31, 2025, Clene had 79 total employees, including 76 full-time and 3 part-time employees. The number of employees increased by 3 or 3.95% compared to the previous year. That makes Clene the 32,857th largest employer in the world and 4,251st in the United States.
Employees
79
Change (1Y)
3
Growth (1Y)
3.95%
Revenue / Employee
$3,013
Profits / Employee
-$339,570
Market Cap
50.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 79 | 3 | 3.95% | 76 | 3 |
| Dec 31, 2024 | 76 | -9 | -10.59% | 75 | 1 |
| Dec 31, 2023 | 85 | -1 | -1.16% | 82 | 3 |
| Dec 31, 2022 | 86 | -16 | -15.69% | 75 | 11 |
| Dec 31, 2021 | 102 | 28 | 37.84% | 95 | 7 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MindWalk Holdings | 77 |
| Xilio Therapeutics | 76 |
| Mereo BioPharma Group | 39 |
| Oncolytics Biotech | 29 |
| Actinium Pharmaceuticals | 27 |
| iBio, Inc. | 23 |
| ImageneBio | 18 |
| RenovoRx | 17 |
CLNN News
- 7 days ago - Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application - Business Wire
- 15 days ago - Clene reports Q3 EPS 5c, consensus (47c) - TheFly
- 15 days ago - Clene Reports Third Quarter 2026 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 15 days ago - Clene Quarterly report: Q3 2026 - Filings
- 15 days ago - Clene Earnings release: Q3 2026 - Filings
- 4 weeks ago - Clene submits CNM-Au8 NDA to FDA for treatment of ALS - TheFly
- 4 weeks ago - Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS - GlobeNewsWire
- 7 weeks ago - Clene Transcript: Lytham Partners Fall 2026 Investor Conference - Transcripts